Jing-Wen Chen Guo-Shu Deng Wen-Shuang Zhang Ming-Ying Zhang Tong Guan Qiang Xu
10.3389/fimmu.2022.942642
Front Immunol
2022 Aug 3;13:942642.
aids tnf adalimumab human immunodeficiency virus rheumatoid arthritis
CC BY
https://pubmed.ncbi.nlm.nih.gov/35990692/
Acquired Immunodeficiency Syndrome / complications Antirheumatic Agents / adverse effects Arthritis, Rheumatoid / complications Arthritis, Rheumatoid / diagnosis Arthritis, Rheumatoid / drug therapy HIV Infections / complications HIV Infections / drug therapy HIV Seropositivity / drug therapy
Acquired Immunodeficiency Syndrome / complications Antirheumatic Agents / adverse effects Arthritis, Rheumatoid / complications Arthritis, Rheumatoid / diagnosis Arthritis, Rheumatoid / drug therapy HIV Infections / complications HIV Infections / drug therapy HIV Seropositivity / drug therapy Case Reports Adalimumab / adverse effects Arthralgia Fatigue / complications Female Follow-Up Studies HIV Humans Middle Aged Antirheumatic Agents Adalimumab
PMC9382239
35990692
Case report: Safety and efficacy of adalimumab in treating difficult-to-treat rheumatoid arthritis in a human immunodeficiency virus-positive patient, one year follow-up
2022